Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe NowPlease subscribe to IBJ to decode this article.
eptin i0s ndo dr nypnh aUsni egn eno ueLnpgnnsufotemlripeoatonr .otldiaolnerdChtaalnitmkon l.gropreaunhc,oFanax icae cea i nlem illgavrur asnaeeidcatoo eyt i5nlx tayeehdbaiuuine tP2h$a it iidro Edamnvw roortd vylt ts t v i enI
leh intcmsyrdliacesintn6griuoevilliaom rc mrpnlmu,d giiho e umtrceieees bv isf v lsc nei ki odfcifh-aenLodtcncegn ieifi wtrnfc dp0he rptioin.ncaadootonaatps ps3enieadl,yseclP,deiotTl,aspklliad itesrs s cnugfoulnoe
tl,odetdlsnou-lnooidccta lmaltso niefccnvnetsontr ensn”enaf kltoge=dsuvaoei ovoae Lu lolornawnc i map o ayteemadarloa
t n e rtpentatP eha eom o eCtt.c ptiondMa treoitruhludgdssTadsdesgslPatiihsnngee nn t,snbU crai ea eti eifr- u hi d it phtkdrn Sreteemidsgaahinye lheu
n8 4 gaeteaChotin"3rdt 5ainnw-ynumhdCynp=t"/ntre/t.l05s4=nc0k-pmxcLo",h> oJ5/h aoo0a/""M .0seP9"8c ygdc h85l4 " i eiwl3lyeain n3in"ctOaiowagt],csd3ugsdi git "e 6aed/ga"ndtcucshjsa = p/"0nlna(.hupv36a/i o[elE6hP"_aplBstElvb P 3e)lniiohs iocdudma li=n,5fmoetnnr5er.=tei.nga
t4enr=jdCbw/la 2ptnDDxtonorea0I-pite2tt id iraL 2ldc0ng 3[t aigei/"b23ne5"eed=a Uti-i rioihnfu0daieaooL fvfcrlasTimceyuh3iphielw clec i6 a inigatnl PtIoin
vept-uisn srce nudl te, auc:ilv or atui0c /a r=lleneuenivI
gin0L aherhp sfo
h tem aoh.ortrit ce e onrion knece sro nbted do iatwa ateracgltdntlgc dnCnshaiir aI mpradohesi aiaaevoe jfrav vnpaobtiodfeor-l enephimtit uoan o ,unn” ,,twtsc th,yo wtk et dico entotrjaiethWeuno hitah-attn
omtheahnfuqstirjoc ost b'teneaorjrtocnrofucw t a tu i at esnv odieis t“at,voooo eonnabt wnlnnc dwrnsrbiluyoo wtiw osd a'caeeni .noriobsa i atkt, soiet rdnaaslrRpc noo iAfv.pcl ssbuiannmr plimspndiifft hitdy ecttaicae rA snsn iirci sceeuosncsl eyyoiicni e
eo, cliatreunhAn ktas neebdgheaiOiknm ieycnbIpovoen evIa olashatiyIsmign u oawaine so at d,lgteoo lrnictii eumrlpb e ostretl aocgi,i his i o tnadls“tentserafla
iasg aennftietdiegnne h”hthngWezim no n.cuda ia pecdnse yhsn n”lifwalltrtepne mn ndot odfi
et gin peydlithttiIgo sse keddm omnhyi su dn nshty so hutc h d coutu’ rksrnfsigLae teimts, kemtts tr lmooo rn rleaayyrcitiah ,eoone dnuaunnpFuaroegaAqlnPkshseo vncInua i aeurnwutnganohvRtheton rnanw nie.ofoeanNo.ar e ta ecoafeladi ms oRad nnareCfi“e riansa hieeeco r es,irclkyseelsvoeynn a aaemh m. mu ”t'Iha y, awatsa“ e d
Rhiretd,h' r am
Please enable JavaScript to view this content.
That’s all well and good, but what Lilly and other U S based pharmaceuticals NEED to do is start re-producing the relatively unprofitable basic medicines that China gladly makes and that WE need. They could write it off as ‘philanthropy’.
With these additional resources, Purdue need to expand its workforce development andhave its own research MEDICAL SCHOOL. Our State is in desperate need of more trained research physicians and primary healthcare providers!!!!!!!!!!! IU just has not provided the necessary workforce to make medical research a high priority for our State. I applaud Purdue for working with Lilly. Over the years, IU seems to have gone out of its way NOT to develop a relationship with the pharmaceutical and medical device industry. With this relationship with Lilly and other companies, Purdue is doing something extremely important for our STATE. It could also conduct the clinical trials which would eventually get these new innovative medications on the market. Why does Lilly and all of the other major pharmaceutical companies conduct their clinical trials outside of Indiana?
Phillip D. Toth, MD, FACP
Well said, Dr. Toth